Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Innate Pharma - Filing #858132

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
57 972 EUR
45 478 EUR
Revenue
57 674 EUR
24 703 EUR
Profit (loss) from discontinued operations
131,000 EUR
7 331 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
19 154 EUR
58 457 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
1 877 EUR
917,000 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
1 828 EUR
26 818 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.